Search

Explore how we use chemotherapy and targeted therapy to treat cancer that has spread beyond the kidney.

… We use different treatments if the kidney cancer has spread through the blood and started new growth in other places. Your care team will talk with you about options for systemic therapy, such as immunotherapy or targeted kidney cancer treatments. Systemic therapy is when medicine is given intravenously

There are many drugs that doctors can use against soft tissue sarcoma. Learn about commonly used drugs as well as promising new approaches.

… There are many drugs that doctors can use against soft tissue sarcoma. The most commonly used chemotherapy drugs include: doxorubicin liposomal doxorubicin (Doxil®) gemcitabine (Gemzar®) and docetaxel (Docefrez®, Taxotere®) ifosfamide (Ifex®) dacarbazine (DTIC-Dome®) eribulin (Halaven®) trabectedin (

Learn about active rare blood disorder and blood cancer clinical trials happening now at Memorial Sloan Kettering, where you may have access to treatments before they’re available elsewhere.

… At Memorial Sloan Kettering, we have significant expertise in caring for people with rare blood disorders. We are committed to improving outcomes for people with these disorders. We believe that research offers the possibility of new treatments. We are focused on developing innovative ideas in our labs

Meet the world-renowned experts who care for people with glioma at Memorial Sloan Kettering.

… Your personal treatment team will include neurologists, brain surgeons, and other experts who’ll use their skills to customize a plan of care that fits your unique needs. They bring expertise, creativity, and passion to every patient. Your team also includes neuropathologists, neuropsychologists, and

If your child has been diagnosed with Ewing sarcoma, Memorial Sloan Kettering is ready to help. Learn more about Ewing sarcoma and our treatment and approach at Memorial Sloan Kettering Cancer Center.

… What is Ewing sarcoma? Ewing sarcoma is a rare form of cancer that most often affects children and teenagers. It commonly affects bones — such as the ribs, upper arm bone, thighbone, and pelvic bone — but can also affect soft tissues, such as those in the pelvis or chest. Ewing sarcoma can cause pain

Learn how our melanoma clinical trials and research might help you or your loved get access to the latest treatments for this serious disease.

… Memorial Sloan Kettering doctors are constantly working to improve treatment for people with melanoma through clinical trials. Participating in a clinical trial may give you access to promising melanoma treatments years before they’re available elsewhere. These studies may offer additional options if

Learn about this rare melanoma, how it’s treated, and why it can be challenging to diagnose.

… Spitzoid melanoma is a type of skin cancer. It begins when the melanocytes in the skin grow out of control and form tumors. Melanocytes are the cells responsible for making melanin, the pigment that determines the color of the skin. Spitzoid melanoma looks very much like an uncommon but benign skin mole

Obtenga información sobre este melanoma poco común, cómo se trata y por qué puede ser difícil de diagnosticar.

… El melanoma spitzoide es un tipo de cáncer de piel. Comienza cuando los melanocitos de la piel crecen sin control y forman tumores. Los melanocitos son las células encargadas de producir melanina, el pigmento que determina el color de la piel. El melanoma spitzoide se parece mucho a un lunar en la piel

… Are you thinking about joining our program? Here’s what you need to know to help you decide. What is the Pancreatic Cancer Screening and Risk Evaluation Program? This program is for people who have a higher risk of getting pancreatic cancer. It is co-led by Dr. Vineet Rolston and Dr. Mengmeng Du . The

Learn about active thymoma and thymic tumor clinical trials happening now at Memorial Sloan Kettering, where you may have access to treatments before they’re available elsewhere.

… Currently, Memorial Sloan Kettering offers the only clinical trial worldwide for people with an advanced but potentially operable thymoma. The trial is part of the effort by our Thymoma Working Group to establish diagnosis and treatment standards for these cancers as well as for thymic tumors and thymic